Submitted by Anonymous (not verified) on 20 September 2023 - 12:30
Opinion/decision on a Paediatric investigation plan (PIP): Rozanolixizumab, decision type: , therapeutic area: , PIP number: P/0410/2022
Source:
Opinion/decision on a Paediatric investigation plan (PIP): Rozanolixizumab, decision type: , therapeutic area: , PIP number: P/0410/2022